Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 391.19%4.66M | -32.17%947.81K | 166.89%1.4M | 292.46%523.54K | -149.91%-272.02K | 120.18%545.03K | 47.81%-2.7M | -75.17%-5.18M | -2.95M |
| Operating revenue | 391.19%4.66M | -32.17%947.81K | 166.89%1.4M | 292.46%523.54K | -149.91%-272.02K | 120.18%545.03K | 47.81%-2.7M | -75.17%-5.18M | ---2.95M |
| Cost of revenue | |||||||||
| Gross profit | |||||||||
| Operating expense | |||||||||
| Selling and administrative expenses | 561.83%932.59K | 42.94%140.91K | -17.95%98.58K | -67.70%120.15K | -26.77%371.94K | -36.26%507.94K | -72.44%796.93K | -28.87%2.89M | --4.07M |
| -Selling and marketing expense | ---- | ---- | ---- | -89.88%17.1356 | 57.64%169.3811 | 100.16%107.4465 | -110.20%-66.78K | 127.42%654.62K | --287.84K |
| -General and administrative expense | 561.83%932.59K | 42.94%140.91K | -17.94%98.58K | -67.69%120.14K | -26.79%371.77K | -41.20%507.83K | -61.39%863.71K | -40.78%2.24M | --3.78M |
| Depreciation amortization depletion | --105K | ---- | ---- | ---- | -18.65%13.19K | 83.97%16.21K | -58.50%8.81K | -34.85%21.23K | --32.59K |
| -Depreciation and amortization | --105K | ---- | ---- | ---- | -18.65%13.19K | 83.97%16.21K | -58.50%8.81K | -34.85%21.23K | --32.59K |
| Operating profit | |||||||||
| Net non-operating interest income (expenses) | |||||||||
| Other net income (expenses) | |||||||||
| Special income (charges) | ---- | ---- | ---- | ---- | --18.01K | ---- | ---- | ---- | ---144.17K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---18.01K | ---- | ---- | ---- | --144.17K |
| Other non-operating income (expenses) | ---316.72K | ---- | ---- | ---- | -99.87%469.0554 | -39.94%350.44K | 47.96%583.52K | -33.61%394.39K | --594.03K |
| Income before tax | 665.22%3.1M | -43.53%405.08K | 360.60%717.35K | 81.21%-275.27K | -3,230.84%-1.46M | 98.84%-43.97K | 60.36%-3.79M | 20.11%-9.57M | -11.98M |
| Income tax | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.29M |
| Earnings from equity interest net of tax | |||||||||
| Net income | 348.77%1.82M | -43.53%405.08K | 360.60%717.35K | 81.21%-275.27K | -3,230.84%-1.46M | 98.84%-43.97K | 60.36%-3.79M | 10.44%-9.57M | -10.69M |
| Net income continuous operations | 348.77%1.82M | -43.53%405.08K | 360.60%717.35K | 81.21%-275.27K | -3,230.84%-1.46M | 98.84%-43.97K | 60.36%-3.79M | 10.44%-9.57M | ---10.69M |
| Noncontrolling interests | |||||||||
| Net income attributable to the company | 348.77%1.82M | -43.53%405.08K | 360.60%717.35K | 81.21%-275.27K | -3,230.84%-1.46M | 98.84%-43.97K | 60.36%-3.79M | 10.44%-9.57M | -10.69M |
| Preferred stock dividends | |||||||||
| Other under preferred stock dividend | |||||||||
| Net income attributable to common stockholders | 348.77%1.82M | -43.53%405.08K | 360.60%717.35K | 81.21%-275.27K | -3,230.84%-1.46M | 98.84%-43.97K | 60.36%-3.79M | 10.44%-9.57M | -10.69M |
| Diluted earnings per share | 291.18%0.0133 | -42.37%0.0034 | 318.52%0.0059 | 88.84%-0.0027 | -1,916.67%-0.0242 | 98.95%-0.0012 | 59.48%-0.1147 | 19.37%-0.283 | -0.351 |
| Basic earnings per share | 226.47%0.0111 | -42.37%0.0034 | 318.52%0.0059 | 88.84%-0.0027 | -1,916.67%-0.0242 | 98.95%-0.0012 | 59.48%-0.1147 | 19.37%-0.283 | -0.351 |
| Dividend per share | |||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |